Skip to main content

Table 2 Components of human whole blood and PRPs

From: Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects

  Platelet concentration (109/L) Leukocyte concentration (109/L) PDGF-AB concentration (ng/mL) TGF-β1  concentration (ng/mL) VEGF concentration (pg/mL) IL-1β concentration (pg/mL) TNF-α concentration (pg/mL)
WB 228.30 ± 50.50 6.18 ± 1.57 8.87 ± 4.67 23.83 ± 12.07 35.92 ± 8.51 11.68 ± 5.90 9.31 ± 5.05
L-PRP 1436.70 ± 257.97 34.58 ± 8.48 42.54 ± 12.65 122.22 ± 43.42 157.89 ± 33.64 93.33 ± 69.88 54.67 ± 27.10
P-PRP 1461.80 ± 189.14 0.18 ± 0.18 43.71 ± 14.39 126.95 ± 35.96 151.82 ± 29.29 3.83 ± 2.61 2.20 ± 0.78
Comparison, P value
 ANOVA <0.001* <0.001* <0.001* <0.001* <0.001* <0.001* <0.001*
 WB vs. L-PRP <0.001* <0.001* <0.001* <0.001* <0.001* <0.001* <0.001*
 WB vs. P-PRP <0.001* 0.036* <0.001* <0.001* <0.001* >0.999 0.979
 L-PRP vs. P-PRP >0.999 <0.001* >0.999 >0.999 >0.999 <0.001* <0.001*
  1. The asterisks indicate the significant differences between groups on ANOVA and with use of the Bonferroni post hoc test for multiple comparisons (P < 0.05)
  2. WB whole blood
\